Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Jun 2026 for Acumen Pharmaceuticals, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Laura Stoppel: trading record in brief
Laura Stoppel appears in our data through filings on Acumen Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 4 June 2025 to 3 June 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 5 June 2026, reports a share grant in Acumen Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Laura Stoppel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
35,500 shares0Common StockSEC:0001628280-26-041263:0
12,800 shares0Common StockSEC:0001576885-25-000084:0
2 of 2 declarations
